What’s the current market cap for ClearPoint Neuro stock?

ClearPoint Neuro (CLPT) has a market cap of $533m as of June 19, 2026.

What is the P/E ratio for ClearPoint Neuro stock?

The price to earnings (P/E) ratio for ClearPoint Neuro (CLPT) stock is 0 as of June 19, 2026.

Does ClearPoint Neuro stock pay dividends?

No, ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders as of June 19, 2026.

When is the next ClearPoint Neuro dividend payment date?

ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders.

What is the beta indicator for ClearPoint Neuro?

ClearPoint Neuro (CLPT) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy ClearPoint Neuro stock | $CLPT Share Price

About ClearPoint Neuro

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

Ticker

$CLPT

Sector

Health

Primary listing

NASDAQ

Employees

172

Headquarters

Solana Beach, United States

Website

www.clearpointneuro.com

ClearPoint Neuro Metrics

BasicAdvanced

$533m

-

-$1.01

1.29

-

What the Analysts think about ClearPoint Neuro

Analyst ratings (Buy, Hold, Sell) for ClearPoint Neuro stock.

Bulls say / Bears say

ClearPoint Neuro reported first-quarter 2026 revenue of $12.1 million, up 43% year-over-year—including $2.3 million from IRRAflow—and achieved a 64% gross margin with full-year guidance of $52–$56 million (MarketScreener)

On April 22, 2026, the FDA granted 510(k) clearance for the Velocity Alpha MR High Speed Surgical Drill System and the company completed its first clinical procedure, expanding its neurosurgical access portfolio (CLEARPOINT Neuro Investor)

ClearPoint Neuro entered a 10-year focused ultrasound development partnership with Sungkyunkwan University, demonstrating successful preclinical blood-brain barrier tracer delivery and broadening its drug delivery ecosystem through robotics and software integration (ACCESS Newswire)

As of March 31, 2026, ClearPoint Neuro held $35.6 million in cash and cash equivalents, while net operating cash flow for Q1 2026 was a $7.97 million outflow, implying less than five quarters of runway without additional funding (Nasdaq)

Capital equipment and software revenue decreased 18% to $0.5 million in Q4 2025, reflecting challenges in driving placements of core hardware and software solutions (SEC)

For the full year 2025, ClearPoint Neuro reported a net loss of $25.54 million, underscoring persistent unprofitability despite double-digit revenue growth (SEC)

Data summarised monthly by Lightyear AI. Last updated on 13 Jun 2026.

ClearPoint Neuro Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

ClearPoint Neuro Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

ClearPoint Neuro News

AllArticlesVideos

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

Accesswire·3 weeks ago

ClearPoint Neuro Q1 Earnings Call Highlights

MarketBeat·1 month ago

ClearPoint Neuro Reports First Quarter 2026 Results

Accesswire·1 month ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

About ClearPoint Neuro

Ticker

Employees

ClearPoint Neuro Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about ClearPoint Neuro

Analyst Ratings

Bulls say / Bears say

ClearPoint Neuro Financial Performance

Income Statement

ClearPoint Neuro Earnings Performance

Earnings per share (EPS)

ClearPoint Neuro News

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro Q1 Earnings Call Highlights

ClearPoint Neuro Reports First Quarter 2026 Results

Buy $CLPT

Lightyear

Legal

Work with us

Bulls say / Bears say

ClearPoint Neuro/$CLPT

About ClearPoint Neuro

Ticker

Employees

ClearPoint Neuro Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about ClearPoint Neuro

Analyst Ratings

Bulls say / Bears say

ClearPoint Neuro Financial Performance

Income Statement

ClearPoint Neuro Earnings Performance

Earnings per share (EPS)

ClearPoint Neuro News

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro Q1 Earnings Call Highlights

ClearPoint Neuro Reports First Quarter 2026 Results

What’s the current market cap for ClearPoint Neuro stock?

What is the P/E ratio for ClearPoint Neuro stock?

Does ClearPoint Neuro stock pay dividends?

When is the next ClearPoint Neuro dividend payment date?

What is the beta indicator for ClearPoint Neuro?

Bulls say / Bears say